Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer

New England Journal of Medicine - United States
doi 10.1056/nejmoa052084
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Massachusetts Medical Society

Related search

Epirubicin/Cyclophosphamide Followed by Docetaxel as Primary Systemic Therapy in Breast Cancer

Annals of Cancer Research and Therapy
Cancer ResearchOncologyPharmacology
2014English

Neoadjuvant 5-Fluorouracil, Epirubicin and Cyclophosphamide Chemotherapy Followed by Docetaxel in Refractory Patients With Locally Advanced Breast Cancer

Oncology Reports
MedicineCancer ResearchOncology
2007English

Bisphosphonates as Adjuvant Therapy for Breast Cancer

Women's Health
Medicine
2006English

Cyclophosphamide and Tamoxifen as Adjuvant Therapies in the Management of Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1988English

Neoadjuvant Chemotherapy of Capecitabine + Epirubicin + Cyclophosphamide Combination Therapy ( 'CEX' Therapy) for HER-2 Negative Breast Cancer, as Retrospective Study in Our Institute

Journal of Nippon Medical School
Medicine
2019English

Current Treatment of Early Breast Cancer: Adjuvant and Neoadjuvant Therapy

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2014English

Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer

Breast Care
SurgeryOncology
2008English

Oral Bisphosphonates as Adjuvant Therapy for Operable Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2006English

Adjuvant Chemotherapy for Early Breast Cancer.

BMJ
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy